Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01558 HEC CJ PHARM
RTNominal unchange12.080 0.000 (0.000%)
Others

29/10/2019 15:41

{I-bank focus}UOBKH lifts HEC Pharm (01558) to HK$58.23

[ET Net News Agency, 29 October 2019] UOB Kay Hian lifted its target price for YiChang
HEC ChangJiang Pharmaceutical (01558) to HK$58.23 from HK$55 and maintained its "buy"
rating.
The research house said HEC Pharma reported promising sales and net income of Rmb1.37bn
and Rmb351mn respectively in 3Q, representing year-on-year growth of 470% and 632%.
Despite the low base in 3Q 2018, sales expansion in the OTC channel helped facilitate the
ultra-high growth.
UOBKH raised its revenue forecasts for 2019 and 2020 by 6.1% to reflect the stronger
growth of Kewei sales. (KL)

Back to Others

Remark: Real time quote last updated: 24/04/2024 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.